Authorization Updates - Effective June 1, 2025
Sentara Health Plans' authorization updates effective June 1, 2025 updated criteria for benign prostatic hypertrophy treatments, cosmetic and reconstructive surgery, augmentative communication devices, hospital beds and keratoconus lenses for Commercial and Medicaid plans, and archived the photodynamic therapy, early inpatient admission and transplant rejection testing policies on June 1, 2025. The notice combined the intestinal, heart-lung and pancreas and islet cell transplant policies into a new Solid Organ Transplantation policy (Surgical 236). Separate updates removed prior authorization for 56 Medicare procedure codes, 49 Medicaid procedure codes and 48 Commercial procedure codes effective April 1, 2025.